GlassScriptPhysician profile
Laura Jacobson
NPI 1558455279
$1,133.65
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $901 · 2020: $192 · 2023: $40.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $40.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $40.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $237.84 | 2019-2023 | |
| Janssen Biotech, INC. | $131.04 | 2019-2020 | |
| Eisai INC. | $129.47 | 2019 | |
| Tesaro, INC. | $88.00 | 2019 | |
| Celgene Corporation | $83.80 | 2019-2020 | |
| Puma Biotechnology, INC. | $74.77 | 2019 | |
| Foundation Medicine, INC. | $71.05 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.67 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $43.06 | 2019 | |
| Amgen INC. | $32.54 | 2019 | |
| Lilly USA, LLC | $31.43 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $30.80 | 2019 | |
| Incyte Corporation | $30.26 | 2019-2020 | |
| Abbvie INC. | $28.35 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $22.12 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $12.90 | 2019 | |
| Spectrum Pharmaceuticals INC. | $12.13 | 2019 | |
| Aurobindo Pharma USA, INC. | $11.42 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Jacobson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.